simplyStocks
Explore all companies →
CRL logo
Charles River Laboratories
CRL · NYSELife Sciences Tools & Services
The economic chain
Follow the chain left → right, from inputs to end demand. Tap any company to trace its links.
Raw inputs
Equipment
Foundry
Chip design
Software
AI demand
Inputs &supplyAnimals, reagents, biopro…Discovery &trialsR&D, CRO services, regula…ManufacturingCell & gene therapy CDMO,…ProductsMedicines, therapiesProviders &patientsDrug developers, patientsNVPNoveprim···Reagent & input suppliersRMSResearch Models (RMS)CRLCharles River LaboratoriesDSADiscovery & Safety (DSA)FDAFDA / EMAMFGManufacturing / CDMOMEDMedicines & therapiesRXLarge pharmaBIOBiotech & CGT developersEDUAcademic & government labsPTPatients
Company details
Market cap
$8.8B
Revenue (FY25)
$4.0B
Rev. growth
-0.9%
Non-GAAP op margin
19.8%
Adj. EPS (FY25)
$10.28
GAAP net income
-$144M
Free cash flow
~$485M
P/E (fwd, adj.)
~17×
In plain English
Charles River is the picks-and-shovels company of drug discovery: it breeds the lab rats and mice researchers experiment on, runs the preclinical safety testing that every new drug must pass before human trials, and quality-tests and manufactures cell and gene therapies. Most of the world's approved drugs in the last few years passed through a Charles River lab — but the business is under pressure from a biotech funding slump and activist Elliott.
In simple terms
What Charles River Laboratories really sells
Charles River is the picks-and-shovels company of drug discovery: it breeds the lab rats and mice researchers experiment on, runs the preclinical safety testing that every new drug must pass before human trials, and quality-tests and manufactures cell and gene therapies. Most of the world's approved drugs in the last few years passed through a Charles River lab — but the business is under pressure from a biotech funding slump and activist Elliott.
Tip · Click any company in the map to learn — in one sentence — what it actually does and why it matters.
Risk read
Elevated
SteadierMore speculative
Why this rating?